Perspectives

Explore Strategic growth fields, hot topics and insights
Home Perspective

Life Sciences

How Early Can We Cure Cancer? Circulating Tumor DNA setting new standards for early detection of Cancer

FutureBridge Oncology consulting team identified 3 transformative themes at the ASCO 2022 that will impact the future.  Antibody...

Life Sciences

Skin Quality Attributes

Quick overview Our client is a global skincare leader who is always determined to bring disruptive innovations ...

Life Sciences

Innovation and Trends in Ophthalmic Diagnostic Devices

Overview Table of Contents Research Methodology ...

Life Sciences

Future of Neuromodulation Devices – Delivering Personalized Care

Neuromodulation is continuously witnessing disruption through advanced technology platforms and slowing shifting its focus to pers...

Prioritization of Assets/MoAs/Targets in SCCHN based on Weak Signals Identification

Life Sciences

Quick overview The client is a leading player in immuno-oncology and aspires to remain a leader with an increas...

Situational Assessment and Strategic Intelligence of Cell Therapy Landscape in Solid Tumors

Life Sciences

Quick overview A leading pharma company wanted to take investment decisions and design a long-term development ...

Diabetes: Scope of Diabetes Management

Life Sciences

Diabetic patients require daily blood glucose checks and insulin injections to maintain their blood glucose levels within the targ...

Orthopedic Implant Associated Infection Management

Life Sciences

The bone and joint degenerative and inflammatory problems affect millions of people worldwide. They account for half of all chroni...

Research Briefing | Antibody Drug Conjugates: ASCO 2022 & Beyond

Life Sciences

FutureBridge Oncology consulting team identified 3 transformative themes at the ASCO 2022 that will impact the future.  Antibo...

Digital Packaging as a Strategy in Medical Devices

Life Sciences Digitalization

The digital revolution in packaging has improved asset and inventory management, track and trace capabilities, end to end visibili...

FutureBridge | Key Highlights from ASCO 2022 – Report #2

Life Sciences Paradigm Shift in R&D

For the first time since 2019, ~31,000 oncologists attended the 2022 ASCO Annual Meeting in person, recapturing the energy of the ...

FutureBridge | Key Highlights from ASCO2022-Report #1

Life Sciences Paradigm Shift in R&D

For the first time since 2019, ~31,000 oncologists attended the 2022 ASCO Annual Meeting in person, recapturing the energy of the ...

Innovations in Drug-delivery Systems to Open New Opportunities for Pharma & Med-techs

Life Sciences

Effective delivery of a drug molecule to its target has always been the focus of researchers around the globe. This not only can r...

Transformative Themes at #ASCO2022

Life Sciences

What to expect at #ASCO2022? The 2022 ASCO annual meeting program will offer insights into the latest research in cancer care, pra...